Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options

• Päätekijät: Amirah Azzeri (Tekijä), Maznah Dahlui (Tekijä), Rosmawati Mohamed (Tekijä), Scott Alexander McDonald (Tekijä), Hafiz Jaafar (Tekijä), Fatiha Hana Shabaruddin (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

IntroductionA scaled-up treatment cascade with direct-acting antiviral (DAA) therapy is necessary to achieve global WHO targets for hepatitis C virus (HCV) elimination in Malaysia. Recently, limited access to sofosbuvir/daclatasvir (SOF/DAC) is available through compulsory licensing, with access to...